Strategic partnerships Leverage Modular Medical’s collaboration history with Glooko and Phillips-Medisize to pursue additional partnerships with diabetes care platforms, device manufacturers, and manufacturing/assembly partners to expand integration, distribution, and scale for MODD1 insulin delivery systems.

Clinical validation Capitalize on recent ADA conference activity and GLP-1R agonist pump data to position MODD1 as a clinically relevant, user-friendly insulin delivery option that complements existing therapies, appealing to clinicians and payer decision-makers.

Governance & leadership Target engagement with newly appointed board member and engineering leadership to explore strategic initiatives, risk management, and product roadmap priorities that align with market needs and accelerate go-to-market timelines.

Investor interest Capitalize on investor conference visibility and ongoing fundraising momentum to secure partnerships or pre-commercial collaborations, emphasizing scalable manufacturing, cost competitiveness, and a clear path to market adoption.

Manufacturing readiness Highlight existing manufacturing collaborations and modular design capabilities to approach contract manufacturers and large device integrators, emphasizing cost-efficient production, quality systems, and supply chain resilience to support rapid scale.